Salix Pharmaceuticals, Inc., et al., v. Novel Laboratories, Inc., C.A. No. 14-213 - GMS, July 10, 2015
Sleet, J. The court construes three terms from the four patents-in suit.
The following terms were considered:
- Without food
The court finds that the patentee expressly surrendered the full scope of the term “core” during prosecution.